Sorry, you need to enable JavaScript to visit this website.

LINCOCIN® (lincomycin HCl) Nonclinical Toxicology

ANIMAL PHARMACOLOGY

In vivo experimental animal studies demonstrated the effectiveness of LINCOCIN preparations (lincomycin) in protecting animals infected with Streptococcus viridans,β-hemolytic Streptococcus, Staphylococcus aureus, Streptococcus pneumoniae and Leptospira pomona. It was ineffective in Klebsiella, Pasteurella, Pseudomonas, Salmonella and Shigella infections.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No